HALO – halozyme therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Halozyme Therapeutics (HALO): Valuation Check After FDA Win and Patent Court Victory [Yahoo! Finance]
Halozyme Therapeutics (HALO) Is Up 7.4% After New ENHANZE NSCLC Win And Patent Injunction - What's Changed [Yahoo! Finance]
Is Halozyme Still Attractively Priced After Its Strong 2025 Share Price Rally? [Yahoo! Finance]
Huonslab Announces Submission of Biologics License Application for Recombinant Human Hyaluronidase ‘HYDIZYME™' [Yahoo! Finance]
Halozyme Therapeutics (NASDAQ:HALO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Form 4 HALOZYME THERAPEUTICS, For: Nov 01 Filed by: Caudill Cortney
Form 4 HALOZYME THERAPEUTICS, For: Dec 09 Filed by: Torley Helen
Form 8-K HALOZYME THERAPEUTICS, For: Dec 04
Form 8-K HALOZYME THERAPEUTICS, For: Dec 04
Form 4 HALOZYME THERAPEUTICS, For: Dec 01 Filed by: Connaughton Bernadette
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.